| 1 | Leber plus disease | Enrichment | AHI1, ALMS1, CC2D2A, CEP290, CFAP410, CRX, INPP5E, IQCB1, LCA5, RP2, RPGRIP1, RPGRIP1L, SPATA7, TULP1 | 11.07 |
| 2 | Senior-loken syndrome 1 | Enrichment | CEP164, CEP290, INVS, IQCB1, NPHP1, NPHP3, NPHP4, SDCCAG8 | 11.07 |
| 3 | Nephronophthisis | Enrichment | AHI1, ANKS6, CEP290, CPLANE1, GLIS2, INTU, INVS, IQCB1, NPHP1, NPHP3, NPHP4 | 10.88 |
| 4 | Bardet-biedl syndrome | Enrichment | ALMS1, BBS4, CEP19, CEP290, IQCB1, MKS1, NPHP1, NPHP4, RPGRIP1L, SCLT1, SDCCAG8, TMEM67, WDPCP | 10.80 |
| 5 | Joubert syndrome 1 | Enrichment | AHI1, B9D1, B9D2, C2CD3, CC2D2A, CEP104, CEP290, CPLANE1, CSPP1, INPP5E, KATNIP, KIAA0586, KIAA0753, MKS1, NPHP1, NPHP3, NPHP4, OFD1, PIBF1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM138, TMEM216, TMEM231, TMEM237, TMEM67 | 10.80 |
| 6 | Retinitis pigmentosa | Enrichment | AHI1, ALMS1, ARL2BP, BBS4, CC2D2A, CEP290, CFAP410, CNGA1, CNGB1, CRX, FAM161A, INPP5E, IQCB1, KIAA0586, KIZ, LCA5, MKS1, NEK2, NPHP4, OFD1, PCARE, POMGNT1, RP1, RP1L1, RP2, RPGRIP1, SPATA7, TMEM216, TOPORS, TTLL5, TUB, TULP1 | 10.74 |
| 7 | Cone-rod dystrophy 2 | Enrichment | ALMS1, CEP290, CEP78, CFAP410, CNGA1, CRX, FAM161A, PCARE, POC1B, RAB28, RP2, RPGRIP1, TTLL5 | 10.74 |
| 8 | Meckel syndrome, type 1 | Enrichment | B9D1, B9D2, CC2D2A, CEP290, CSPP1, EVC2, KIAA0586, MKS1, RPGRIP1, RPGRIP1L, TCTN1, TCTN2, TCTN3, TMEM107, TMEM138, TMEM17, TMEM216, TMEM231, TMEM237, TMEM67 | 10.68 |
| 9 | Isolated joubert syndrome | Enrichment | AHI1, B9D1, B9D2, CEP104, CEP120, CEP41, CPLANE1, CSPP1, HYLS1, INPP5E, KATNIP, KIAA0586, KIAA0753, MKS1, OFD1, PIBF1, SUFU, TCTN1, TCTN2, TCTN3, TMEM237, TMEM67 | 10.61 |
| 10 | Hereditary retinal dystrophy | Enrichment | AHI1, ALMS1, ARL2BP, BBS4, CC2D2A, CEP164, CEP290, CEP78, CFAP410, CNGA1, CNGB1, CRX, FAM161A, INPP5E, IQCB1, KIAA0586, KIZ, LCA5, NEK2, NPHP1, NPHP4, OFD1, PCARE, POC1B, POMGNT1, RAB28, RP1, RP1L1, RP2, RPGRIP1, SDCCAG8, SPATA7, TOPORS, TTLL5, TUB, TULP1 | 10.57 |
| 11 | Fundus dystrophy | Enrichment | AHI1, ALMS1, ARL2BP, BBS4, CC2D2A, CEP164, CEP290, CEP78, CFAP410, CNGA1, CNGB1, CRX, FAM161A, INPP5E, IQCB1, KIAA0586, KIZ, LCA5, NEK2, NPHP1, NPHP4, OFD1, PCARE, POC1B, POMGNT1, RAB28, RP1, RP1L1, RP2, RPGRIP1, SDCCAG8, SPATA7, TOPORS, TTLL5, TUB, TULP1 | 10.57 |
| 12 | Orofaciodigital syndrome vi | Enrichment | CPLANE1, KIAA0753, KIF7, OFD1, TCTN3, TMEM216, TMEM231, TOPORS | 10.56 |
| 13 | Ciliopathy | Enrichment | CC2D2A, CEP83, KATNIP, RPGRIP1L, TBC1D32, TCTN3, TMEM231 | 10.55 |
| 14 | Infantile nephronophthisis | Enrichment | ANKS6, CEP83, INVS, NEK8, NPHP3, ZNF423 | 10.52 |
| 15 | Arima syndrome | Enrichment | CC2D2A, CEP290, TMEM138, TMEM216, TMEM231, TMEM237, ZNF423 | 10.35 |
| 16 | Coach syndrome 1 | Enrichment | CC2D2A, INPP5E, OFD1, RPGRIP1L, TMEM67 | 10.14 |
| 17 | Joubert syndrome with ocular defect | Enrichment | AHI1, CEP120, CEP41, INPP5E, MKS1 | 10.14 |
| 18 | Polycystic kidney disease | Enrichment | CC2D2A, CEP290, NPHP3, PKD1, PKD2, PKHD1 | 8.32 |
| 19 | Stargardt disease 1 | Enrichment | ALMS1, CRX, LCA5, PCARE, SPATA7, TULP1 | 6.85 |
| 20 | Visceral heterotaxy 5 | Enrichment | ANKS3, CFAP52, CFAP53, DNAAF19, NME7, PKD1L1 | 6.76 |
| 21 | Leber congenital amaurosis 1 | Enrichment | CRX, LCA5, RPGRIP1, TULP1 | 6.52 |
| 22 | Cystic kidney disease | Enrichment | CC2D2A, PKD1, PKHD1, TMEM67 | 6.27 |
| 23 | Meckel syndrome, type 6 | Enrichment | CC2D2A, CEP290, TCTN2 | 6.26 |
| 24 | Joubert syndrome 4 | Enrichment | NPHP1, RPGRIP1L, TMEM237 | 5.66 |
| 25 | Oligohydramnios | Enrichment | CC2D2A, PKHD1, TMEM67 | 5.66 |
| 26 | Orofaciodigital syndrome | Enrichment | OFD1, TMEM107, WDPCP | 5.66 |
| 27 | Autosomal dominant polycystic kidney disease | Enrichment | NEK8, PKD1, PKD2, PKHD1 | 5.25 |
| 28 | Eye disease | Enrichment | AHI1, ALMS1, RP2, RPGRIP1, TULP1 | 5.03 |
| 29 | Polycystic kidney disease 4 with or without polycystic liver disease | Enrichment | PKD1, PKD2, PKHD1 | 4.53 |
| 30 | Polydactyly | Enrichment | CC2D2A, CPLANE1, MKS1 | 4.35 |
| 31 | Pallister-hall-like syndrome | Enrichment | SCLT1, SMO | 4.17 |
| 32 | Orofaciodigital syndrome ii | Enrichment | INTU, NEK1 | 4.17 |
| 33 | Leber congenital amaurosis 6 | Enrichment | MKS1, RPGRIP1 | 4.17 |
| 34 | Joubert syndrome 10 | Enrichment | CC2D2A, OFD1 | 4.17 |
| 35 | Senior-boichis syndrome | Enrichment | DCDC2, TMEM67 | 4.17 |
| 36 | Short-rib thoracic dysplasia 6 with or without polydactyly | Enrichment | EVC, EVC2, NEK1 | 3.94 |
| 37 | Bardet-biedl syndrome 1 | Enrichment | BBS4, CCDC28B, KIF7 | 3.83 |
| 38 | Short-rib thoracic dysplasia 1 with or without polydactyly | Enrichment | CEP120, EVC2, KIAA0586, KIAA0753 | 3.82 |
| 39 | Acrocallosal syndrome | Enrichment | GLI3, KIF7 | 3.70 |
| 40 | Hydrolethalus syndrome | Enrichment | HYLS1, KIF7 | 3.70 |
| 41 | End stage renal disease | Enrichment | ALMS1, PKD1 | 3.70 |
| 42 | Renal-hepatic-pancreatic dysplasia | Enrichment | NEK8, NPHP3 | 3.70 |
| 43 | Late-onset nephronophthisis | Enrichment | NPHP3, XPNPEP3 | 3.70 |
| 44 | Polydactyly, postaxial, type a1 | Enrichment | CC2D2A, GLI3, TULP1 | 3.63 |
| 45 | Kidney disease | Enrichment | CEP290, NPHP4, PKD1 | 3.63 |
| 46 | Microform holoprosencephaly | Enrichment | GLI2, SUFU, ZIC2 | 3.55 |
| 47 | Dandy-walker syndrome | Enrichment | CSPP1, HYLS1, PIBF1 | 3.47 |
| 48 | Orofaciodigital syndrome iii | Enrichment | OFD1, TMEM231 | 3.40 |
| 49 | Bardet-biedl syndrome 14 | Enrichment | CEP290, TMEM67 | 3.40 |
| 50 | Anencephaly | Enrichment | CC2D2A, HYLS1 | 3.40 |
| 51 | Polycystic liver disease 1 with or without kidney cysts | Enrichment | PKD1, PKD2 | 3.18 |
| 52 | Polycystic kidney disease 3 with or without polycystic liver disease | Enrichment | PKD1, PKHD1 | 3.18 |
| 53 | Polycystic liver disease 1 | Enrichment | PKD1, PKD2 | 3.18 |
| 54 | Joubert syndrome with jeune asphyxiating thoracic dystrophy | Enrichment | CSPP1, KIAA0586 | 3.18 |
| 55 | Cone dystrophy | Enrichment | CFAP410, RAB28, RPGRIP1 | 3.01 |
| 56 | Weyers acrofacial dysostosis | Enrichment | EVC, EVC2 | 3.00 |
| 57 | Renal dysplasia, cystic | Enrichment | CEP290, PKD1 | 3.00 |
| 58 | Multicystic kidney dysplasia | Enrichment | PKD1, PKD2 | 3.00 |
| 59 | Multicystic dysplastic kidney | Enrichment | PKD1, PKD2 | 3.00 |
| 60 | Jeune thoracic dystrophy | Enrichment | EVC2, KIAA0586, KIAA0753 | 2.96 |
| 61 | Polycystic kidney disease 1 with or without polycystic liver disease | Enrichment | PKD1, PKD2 | 2.86 |
| 62 | Polycystic kidney disease 1 | Enrichment | PKD1, PKD2 | 2.86 |
| 63 | Asphyxiating thoracic dystrophy | Enrichment | EVC2, KIAA0586, KIAA0753 | 2.81 |
| 64 | Short-rib thoracic dysplasia 12 | Enrichment | EVC2, NEK1 | 2.74 |
| 65 | Congenital nervous system abnormality | Enrichment | CEP290, POMGNT1, TMEM216, TMEM67, ZIC2 | 2.74 |
| 66 | Nervous system disease | Enrichment | CEP290, POMGNT1, TMEM216, TMEM67, ZIC2 | 2.74 |
| 67 | Ellis-van creveld syndrome | Enrichment | EVC, EVC2 | 2.63 |
| 68 | Cakut | Enrichment | NPHP1, NPHP4, TMEM231 | 2.57 |
| 69 | Epilepsy, myoclonic juvenile | Enrichment | CILK1, EFHC1 | 2.45 |
| 70 | Meningioma | Enrichment | SMO, SUFU | 2.37 |
| 71 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | CC2D2A, INPP5E | 2.30 |
| 72 | Clubfoot | Enrichment | CC2D2A, INPP5E | 2.30 |
| 73 | Chronic kidney disease | Enrichment | MKS1, PKD2 | 2.30 |
| 74 | Medulloblastoma | Enrichment | GPR161, SUFU | 2.24 |
| 75 | Septopreoptic holoprosencephaly | Enrichment | GLI2, ZIC2 | 2.18 |
| 76 | Midline interhemispheric variant of holoprosencephaly | Enrichment | GLI2, ZIC2 | 2.18 |
| 77 | Hydrocephalus, congenital, 1 | Enrichment | KIF7, OFD1 | 2.12 |
| 78 | Hypertension | Enrichment | PKD1, PKD2 | 2.12 |
| 79 | Lobar holoprosencephaly | Enrichment | GLI2, ZIC2 | 2.12 |
| 80 | Pallister-hall syndrome | Enrichment | GLI3 | 2.08 |
| 81 | Greig cephalopolysyndactyly syndrome | Enrichment | GLI3 | 2.08 |
| 82 | Pneumothorax, primary spontaneous | Enrichment | FLCN | 2.08 |
| 83 | Congenital heart defects, hamartomas of tongue, and polysyndactyly | Enrichment | WDPCP | 2.08 |
| 84 | Retinitis pigmentosa 23 | Enrichment | OFD1 | 2.08 |
| 85 | Intellectual developmental disorder, x-linked 99 | Enrichment | USP9X | 2.08 |
| 86 | Simpson-golabi-behmel syndrome, type 2 | Enrichment | OFD1 | 2.08 |
| 87 | Curry-jones syndrome | Enrichment | SMO | 2.08 |
| 88 | Joubert syndrome 7 | Enrichment | RPGRIP1L | 2.08 |
| 89 | Epilepsy, juvenile absence 1 | Enrichment | EFHC1 | 2.08 |
| 90 | Nephronophthisis 7 | Enrichment | GLIS2 | 2.08 |
| 91 | Joubert syndrome 2 | Enrichment | TMEM216 | 2.08 |
| 92 | Joubert syndrome 3 | Enrichment | AHI1 | 2.08 |
| 93 | Polydactyly, preaxial iv | Enrichment | GLI3 | 2.08 |
| 94 | Senior-loken syndrome 5 | Enrichment | IQCB1 | 2.08 |
| 95 | Leber congenital amaurosis 15 | Enrichment | TULP1 | 2.08 |
| 96 | Retinitis pigmentosa 82 with or without situs inversus | Enrichment | ARL2BP | 2.08 |
| 97 | Hydrolethalus syndrome 2 | Enrichment | KIF7 | 2.08 |
| 98 | Orofaciodigital syndrome v | Enrichment | DDX59 | 2.08 |
| 99 | Orofaciodigital syndrome xiv | Enrichment | C2CD3 | 2.08 |
| 100 | Renal-hepatic-pancreatic dysplasia 2 | Enrichment | NEK8 | 2.08 |
| 101 | Microcephaly and chorioretinopathy, autosomal recessive, 2 | Enrichment | PLK4 | 2.08 |
| 102 | Short-rib thoracic dysplasia 14 with polydactyly | Enrichment | KIAA0586 | 2.08 |
| 103 | Ciliary dyskinesia, primary, 17 | Enrichment | DNAAF19 | 2.08 |
| 104 | Heterotaxy, visceral, 6, autosomal | Enrichment | CFAP53 | 2.08 |
| 105 | Meckel syndrome, type 3 | Enrichment | TMEM67 | 2.08 |
| 106 | Leber congenital amaurosis 7 | Enrichment | CRX | 2.08 |
| 107 | Arthrogryposis, perthes disease, and upward gaze palsy | Enrichment | NEK9 | 2.08 |
| 108 | Nevus comedonicus | Enrichment | NEK9 | 2.08 |
| 109 | Culler-jones syndrome | Enrichment | GLI2 | 2.08 |
| 110 | Bardet-biedl syndrome 4 | Enrichment | BBS4 | 2.08 |
| 111 | Joubert syndrome 6 | Enrichment | TMEM67 | 2.08 |
| 112 | Orofaciodigital syndrome xv | Enrichment | KIAA0753 | 2.08 |
| 113 | Cone-rod dystrophy and hearing loss 1 | Enrichment | CEP78 | 2.08 |
| 114 | Cone-rod dystrophy 18 | Enrichment | RAB28 | 2.08 |
| 115 | Nephronophthisis 9 | Enrichment | NEK8 | 2.08 |
| 116 | Retinitis pigmentosa 98 | Enrichment | TMEM216 | 2.08 |
| 117 | Joubert syndrome 38 | Enrichment | KIAA0753 | 2.08 |
| 118 | Retinitis pigmentosa 88 | Enrichment | RP1L1 | 2.08 |
| 119 | Rhyns syndrome | Enrichment | TMEM67 | 2.08 |
| 120 | Retinitis pigmentosa 93 | Enrichment | CC2D2A | 2.08 |
| 121 | Joubert syndrome 32 | Enrichment | SUFU | 2.08 |
| 122 | Birt-hogg-dube syndrome | Enrichment | FLCN | 2.08 |
| 123 | Epilepsy, juvenile myoclonic 10 | Enrichment | CILK1 | 2.08 |
| 124 | Meckel syndrome, type 9 | Enrichment | B9D1 | 2.08 |
| 125 | Spermatogenic failure 27 | Enrichment | AK7 | 2.08 |
| 126 | Al-gazali-bakalinova syndrome | Enrichment | KIF7 | 2.08 |
| 127 | Orofaciodigital syndrome ix | Enrichment | TBC1D32 | 2.08 |
| 128 | Intellectual developmental disorder, x-linked 99, syndromic, female-restricted | Enrichment | USP9X | 2.08 |
| 129 | Lowe oculocerebrorenal syndrome | Enrichment | OCRL | 2.08 |
| 130 | Short-rib thoracic dysplasia 21 without polydactyly | Enrichment | KIAA0753 | 2.08 |
| 131 | Joubert syndrome 9 | Enrichment | CC2D2A | 2.08 |
| 132 | Spinocerebellar ataxia 11 | Enrichment | TTBK2 | 2.08 |
| 133 | Coach syndrome 2 | Enrichment | CC2D2A | 2.08 |
| 134 | Coach syndrome 3 | Enrichment | RPGRIP1L | 2.08 |
| 135 | Morbid obesity and spermatogenic failure | Enrichment | CEP19 | 2.08 |
| 136 | Bardet-biedl syndrome 15 | Enrichment | WDPCP | 2.08 |
| 137 | Joubert syndrome 33 | Enrichment | PIBF1 | 2.08 |
| 138 | Cone-rod dystrophy 13 | Enrichment | RPGRIP1 | 2.08 |
| 139 | Meckel syndrome, type 2 | Enrichment | TMEM216 | 2.08 |
| 140 | Senior-loken syndrome 4 | Enrichment | NPHP4 | 2.08 |
| 141 | Ulnar/fibular ray defect and brachydactyly | Enrichment | RP1L1 | 2.08 |
| 142 | Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome | Enrichment | INPP5E | 2.08 |
| 143 | Holoprosencephaly 9 | Enrichment | GLI2 | 2.08 |
| 144 | Retinitis pigmentosa 31 | Enrichment | TOPORS | 2.08 |
| 145 | Joubert syndrome 15 | Enrichment | CEP41 | 2.08 |
| 146 | Endocrine-cerebroosteodysplasia | Enrichment | CILK1 | 2.08 |
| 147 | Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis | Enrichment | POC1A | 2.08 |
| 148 | Retinitis pigmentosa 54 | Enrichment | PCARE | 2.08 |
| 149 | Joubert syndrome 16 | Enrichment | TMEM138 | 2.08 |
| 150 | Occult macular dystrophy | Enrichment | RP1L1 | 2.08 |
| 151 | Nephronophthisis 14 | Enrichment | ZNF423 | 2.08 |
| 152 | Nephronophthisis 15 | Enrichment | CEP164 | 2.08 |
| 153 | Alsahan-harris syndrome | Enrichment | TBC1D32 | 2.08 |
| 154 | Retinitis pigmentosa 67 | Enrichment | NEK2 | 2.08 |
| 155 | Cone-rod dystrophy 19 | Enrichment | TTLL5 | 2.08 |
| 156 | Microcephaly and chorioretinopathy 2 | Enrichment | PLK4 | 2.08 |
| 157 | Meckel syndrome, type 5 | Enrichment | RPGRIP1L | 2.08 |
| 158 | Nephronophthisis 11 | Enrichment | TMEM67 | 2.08 |
| 159 | Peritonitis | Enrichment | TMEM67 | 2.08 |
| 160 | Meckel syndrome, type 10 | Enrichment | B9D2 | 2.08 |
| 161 | Retinitis pigmentosa 100 | Enrichment | TBC1D32 | 2.08 |
| 162 | Retinitis pigmentosa 45 | Enrichment | CNGB1 | 2.08 |
| 163 | Joubert syndrome 27 | Enrichment | B9D1 | 2.08 |
| 164 | Cranioectodermal dysplasia 6 | Enrichment | CILK1 | 2.08 |
| 165 | Meckel syndrome, type 8 | Enrichment | TCTN2 | 2.08 |
| 166 | Joubert syndrome 13 | Enrichment | TCTN1 | 2.08 |
| 167 | Lethal congenital contracture syndrome 10 | Enrichment | NEK9 | 2.08 |
| 168 | Short-rib thoracic dysplasia 13 with or without polydactyly | Enrichment | CEP120 | 2.08 |
| 169 | Joubert syndrome 23 | Enrichment | KIAA0586 | 2.08 |
| 170 | Osteochondrodysplasia, complex lethal, symoens-barnes-gistelinck type | Enrichment | TAPT1 | 2.08 |
| 171 | Joubert syndrome 31 | Enrichment | CEP120 | 2.08 |
| 172 | Amyotrophic lateral sclerosis 24 | Enrichment | NEK1 | 2.08 |
| 173 | Polycystic kidney disease 8 | Enrichment | NEK8 | 2.08 |
| 174 | Juvenile absence epilepsy | Enrichment | EFHC1 | 2.08 |
| 175 | Heterotaxy, visceral, 10, autosomal, with male infertility | Enrichment | CFAP52 | 2.08 |
| 176 | Joubert syndrome 24 | Enrichment | TCTN2 | 2.08 |
| 177 | Multiple epiphyseal dysplasia, al-gazali type | Enrichment | KIF7 | 2.08 |
| 178 | Nephronophthisis 18 | Enrichment | CEP83 | 2.08 |
| 179 | Ulnar/fibula ray defect-brachydactyly syndrome | Enrichment | RP1L1 | 2.08 |
| 180 | Retinitis pigmentosa with or without situs inversus | Enrichment | ARL2BP | 2.08 |
| 181 | Female-restricted syndromic x-linked intellectual disability 99 | Enrichment | USP9X | 2.08 |
| 182 | Cephalocele | Enrichment | PIBF1 | 2.08 |
| 183 | Pancreatitis | Enrichment | TMEM67 | 2.08 |
| 184 | Renovascular hypertension | Enrichment | PKD1 | 2.08 |
| 185 | Familial spontaneous pneumothorax | Enrichment | FLCN | 2.08 |
| 186 | Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome | Enrichment | GLI2 | 2.08 |
| 187 | Polycystic liver disease | Enrichment | PKD2, PKHD1 | 2.07 |
| 188 | Autosomal dominant polycystic liver disease | Enrichment | PKD2, PKHD1 | 2.07 |
| 189 | Alobar holoprosencephaly | Enrichment | GLI2, ZIC2 | 2.07 |
| 190 | Semilobar holoprosencephaly | Enrichment | GLI2, ZIC2 | 2.02 |
| 191 | Spastic ataxia | Enrichment | CEP290, MKS1, TMEM67 | 2.02 |
| 192 | Craniosynostosis | Enrichment | GLI2, GLI3 | 1.93 |
| 193 | Visceral heterotaxy | Enrichment | CFAP53, PKD1L1 | 1.85 |
| 194 | Birt-hogg-dube syndrome 1 | Enrichment | FLCN | 1.78 |
| 195 | Stromme syndrome | Enrichment | CENPF | 1.78 |
| 196 | Nephronophthisis 1 | Enrichment | NPHP1 | 1.78 |
| 197 | Chylomicron retention disease | Enrichment | DCDC2 | 1.78 |
| 198 | Muscular dystrophy-dystroglycanopathy , type a, 3 | Enrichment | POMGNT1 | 1.78 |
| 199 | Spondyloepiphyseal dysplasia tarda, x-linked | Enrichment | OFD1 | 1.78 |
| 200 | Retinitis pigmentosa 2 | Enrichment | RP2 | 1.78 |
| 201 | Orofaciodigital syndrome i | Enrichment | OFD1 | 1.78 |
| 202 | Dent disease 2 | Enrichment | OCRL | 1.78 |
| 203 | Nephronophthisis 4 | Enrichment | NPHP4 | 1.78 |
| 204 | Nephronophthisis-like nephropathy 1 | Enrichment | XPNPEP3 | 1.78 |
| 205 | Leber congenital amaurosis 3 | Enrichment | SPATA7 | 1.78 |
| 206 | Holoprosencephaly 5 | Enrichment | ZIC2 | 1.78 |
| 207 | Joubert syndrome 14 | Enrichment | TMEM237 | 1.78 |
| 208 | Joubert syndrome 17 | Enrichment | CPLANE1 | 1.78 |
| 209 | Lethal congenital contracture syndrome 8 | Enrichment | ADCY6 | 1.78 |
| 210 | Hydrolethalus syndrome 1 | Enrichment | HYLS1 | 1.78 |
| 211 | White-sutton syndrome | Enrichment | GLI2 | 1.78 |
| 212 | Joubert syndrome 18 | Enrichment | TCTN3 | 1.78 |
| 213 | Muscular dystrophy-dystroglycanopathy , type b, 3 | Enrichment | POMGNT1 | 1.78 |
| 214 | Meckel syndrome, type 11 | Enrichment | TMEM231 | 1.78 |
| 215 | Orofaciodigital syndrome iv | Enrichment | TCTN3 | 1.78 |
| 216 | Deafness, autosomal recessive 66 | Enrichment | DCDC2 | 1.78 |
| 217 | Neurodevelopmental disorder with microcephaly and gray sclerae | Enrichment | HYLS1 | 1.78 |
| 218 | Heterotaxy, visceral, 8, autosomal | Enrichment | PKD1L1 | 1.78 |
| 219 | Carpenter syndrome 1 | Enrichment | RAB23 | 1.78 |
| 220 | Joubert syndrome 26 | Enrichment | KATNIP | 1.78 |
| 221 | Nephronophthisis 16 | Enrichment | ANKS6 | 1.78 |
| 222 | Polycystic liver disease 2 with or without kidney cysts | Enrichment | LCA5 | 1.78 |
| 223 | Spondylometaphyseal dysplasia, axial | Enrichment | CFAP410 | 1.78 |
| 224 | Nephronophthisis 19 | Enrichment | DCDC2 | 1.78 |
| 225 | Orofaciodigital syndrome xvi | Enrichment | TMEM107 | 1.78 |
| 226 | Developmental and epileptic encephalopathy 88 | Enrichment | WDPCP | 1.78 |
| 227 | Retinitis pigmentosa 49 | Enrichment | CNGA1 | 1.78 |
| 228 | Retinal dystrophy with or without macular staphyloma | Enrichment | CFAP410 | 1.78 |
| 229 | Leber congenital amaurosis 5 | Enrichment | LCA5 | 1.78 |
| 230 | Retinitis pigmentosa 14 | Enrichment | TULP1 | 1.78 |
| 231 | Tibial hemimelia | Enrichment | GLI3 | 1.78 |
| 232 | Joubert syndrome 20 | Enrichment | TMEM231 | 1.78 |
| 233 | Joubert syndrome 21 | Enrichment | CSPP1 | 1.78 |
| 234 | Senior-loken syndrome 7 | Enrichment | SDCCAG8 | 1.78 |
| 235 | Spondyloepiphyseal dysplasia tarda | Enrichment | OFD1 | 1.78 |
| 236 | Synpolydactyly | Enrichment | GLI3 | 1.78 |
| 237 | Retinitis pigmentosa 28 | Enrichment | FAM161A | 1.78 |
| 238 | Bardet-biedl syndrome 13 | Enrichment | MKS1 | 1.78 |
| 239 | Congenital fibrosarcoma | Enrichment | SUFU | 1.78 |
| 240 | Retinitis pigmentosa 76 | Enrichment | POMGNT1 | 1.78 |
| 241 | Bardet-biedl syndrome 16 | Enrichment | SDCCAG8 | 1.78 |
| 242 | Hypopituitarism | Enrichment | TBC1D32 | 1.78 |
| 243 | Retinal dystrophy and obesity | Enrichment | TUB | 1.78 |
| 244 | Short-rib thoracic dysplasia 7 with or without polydactyly | Enrichment | INTU | 1.78 |
| 245 | Dextrocardia | Enrichment | CFAP53 | 1.78 |
| 246 | Joubert syndrome 28 | Enrichment | MKS1 | 1.78 |
| 247 | Sclerosing cholangitis, neonatal | Enrichment | DCDC2 | 1.78 |
| 248 | Polycystic kidney disease 3 | Enrichment | PKD1 | 1.78 |
| 249 | Intellectual developmental disorder, autosomal recessive 77 | Enrichment | CEP104 | 1.78 |
| 250 | Congenital muscular dystrophy-dystroglycanopathy type a3 | Enrichment | POMGNT1 | 1.78 |
| 251 | Basal cell nevus syndrome 2 | Enrichment | SUFU | 1.78 |
| 252 | Postaxial polydactyly type b | Enrichment | GLI3 | 1.78 |
| 253 | Short femur | Enrichment | INPP5E | 1.78 |
| 254 | Cerebellar malformation | Enrichment | TMEM67 | 1.78 |
| 255 | Joubert syndrome 29 | Enrichment | TMEM107 | 1.78 |
| 256 | Acute megakaryoblastic leukemia in children without down syndrome | Enrichment | GLIS2 | 1.78 |
| 257 | Isolated neonatal sclerosing cholangitis | Enrichment | DCDC2 | 1.78 |
| 258 | Hirschsprung disease 1 | Enrichment | GLI3, SMO | 1.62 |
| 259 | Severe covid-19 | Enrichment | CC2D2A, CENPF | 1.62 |
| 260 | Alstrom syndrome | Enrichment | ALMS1 | 1.61 |
| 261 | Retinitis pigmentosa 1 | Enrichment | RP1 | 1.61 |
| 262 | Homocystinuria due to cystathionine beta-synthase deficiency | Enrichment | PKHD1 | 1.61 |
| 263 | Simpson-golabi-behmel syndrome, type 1 | Enrichment | OFD1 | 1.61 |
| 264 | Aarskog-scott syndrome | Enrichment | GLI3 | 1.61 |
| 265 | Dyslexia 2 | Enrichment | DCDC2 | 1.61 |
| 266 | Polycystic kidney disease, infantile severe, with tuberous sclerosis | Enrichment | PKD1 | 1.61 |
| 267 | Retinitis pigmentosa 3 | Enrichment | RP2 | 1.61 |
| 268 | Caroli disease, isolated | Enrichment | PKHD1 | 1.61 |
| 269 | Meckel syndrome, type 7 | Enrichment | NPHP3 | 1.61 |
| 270 | Nephronophthisis 2 | Enrichment | INVS | 1.61 |
| 271 | Senior-loken syndrome 6 | Enrichment | CEP290 | 1.61 |
| 272 | Nephronophthisis 3 | Enrichment | NPHP3 | 1.61 |
| 273 | Spinocerebellar ataxia 10 | Enrichment | ATXN10 | 1.61 |
| 274 | Joubert syndrome 5 | Enrichment | CEP290 | 1.61 |
| 275 | Muscular dystrophy-dystroglycanopathy , type c, 3 | Enrichment | POMGNT1 | 1.61 |
| 276 | Retinitis pigmentosa 69 | Enrichment | KIZ | 1.61 |
| 277 | Tuberous sclerosis 2 | Enrichment | PKD1 | 1.61 |
| 278 | Cone-rod dystrophy 20 | Enrichment | POC1B | 1.61 |
| 279 | Joubert syndrome 25 | Enrichment | CEP104 | 1.61 |
| 280 | Polycystic kidney disease 2 with or without polycystic liver disease | Enrichment | PKD2 | 1.61 |
| 281 | Joubert syndrome 36 | Enrichment | TBC1D32 | 1.61 |
| 282 | Orofaciodigital syndrome xvii | Enrichment | INTU | 1.61 |
| 283 | Short-rib thoracic dysplasia 20 with polydactyly | Enrichment | INTU | 1.61 |
| 284 | Dent disease | Enrichment | OCRL | 1.61 |
| 285 | Caroli disease | Enrichment | PKHD1 | 1.61 |
| 286 | Umbilical hernia | Enrichment | GLI3 | 1.61 |
| 287 | Polycystic kidney disease 4 | Enrichment | PKHD1 | 1.61 |
| 288 | Polycystic kidney disease 2 | Enrichment | PKD2 | 1.61 |
| 289 | Congenital muscular dystrophy-dystroglycanopathy type a | Enrichment | POMGNT1 | 1.61 |
| 290 | Interstitial lung disease | Enrichment | INPP5E | 1.61 |
| 291 | Potocki-lupski syndrome | Enrichment | FLCN | 1.61 |
| 292 | Chromophobe renal cell carcinoma | Enrichment | FLCN | 1.61 |
| 293 | Desmoplastic/nodular medulloblastoma | Enrichment | SUFU | 1.61 |
| 294 | Cog7-congenital disorder of glycosylation | Enrichment | CEP290 | 1.61 |
| 295 | Respiratory failure | Enrichment | INPP5E | 1.61 |
| 296 | Occipital encephalocele | Enrichment | CEP290 | 1.61 |
| 297 | Hypomyelination neuropathy-arthrogryposis syndrome | Enrichment | ADCY6 | 1.61 |
| 298 | Hyperpigmentation of the skin | Enrichment | USP9X | 1.61 |
| 299 | Connective tissue disease | Enrichment | NEK1, OFD1 | 1.54 |
| 300 | Retinitis pigmentosa 91 | Enrichment | CRX | 1.49 |
| 301 | Renal-hepatic-pancreatic dysplasia 1 | Enrichment | NPHP3 | 1.49 |
| 302 | Krabbe disease | Enrichment | SPATA7 | 1.49 |
| 303 | Cystinuria | Enrichment | CENPF | 1.49 |
| 304 | Erythrocytosis, familial, 2 | Enrichment | CEP120 | 1.49 |
| 305 | Astigmatism | Enrichment | SCLT1 | 1.49 |
| 306 | Amyotrophy, monomelic | Enrichment | CPLANE1 | 1.49 |
| 307 | Meckel syndrome, type 4 | Enrichment | CEP290 | 1.49 |
| 308 | Pregnancy loss, recurrent 3 | Enrichment | PKHD1 | 1.49 |
| 309 | Ciliary dyskinesia, primary, 29 | Enrichment | CENPF | 1.49 |
| 310 | Meckel syndrome 13 | Enrichment | TMEM107 | 1.49 |
| 311 | Syndactyly | Enrichment | TULP1 | 1.49 |
| 312 | Color blindness | Enrichment | RPGRIP1 | 1.49 |
| 313 | Tuberous sclerosis | Enrichment | PKD1 | 1.49 |
| 314 | Pilocytic astrocytoma | Enrichment | FLCN | 1.49 |
| 315 | Autosomal recessive chorioretinopathy-microcephaly syndrome | Enrichment | PLK4 | 1.49 |
| 316 | Oculomotor apraxia | Enrichment | SUFU | 1.49 |
| 317 | Male infertility due to gonadal dysgenesis or sperm disorder | Enrichment | KIF7 | 1.49 |
| 318 | Choroidal dystrophy, central areolar, 1 | Enrichment | TTLL5 | 1.39 |
| 319 | Leber congenital amaurosis 10 | Enrichment | CEP290 | 1.39 |
| 320 | Goldberg-shprintzen syndrome | Enrichment | NEK9 | 1.39 |
| 321 | Holoprosencephaly | Enrichment | ZIC2 | 1.39 |
| 322 | Polyhydramnios | Enrichment | HYLS1 | 1.39 |
| 323 | Night blindness | Enrichment | CEP290 | 1.39 |
| 324 | Hemangioma | Enrichment | PKD1 | 1.39 |
| 325 | Farsightedness | Enrichment | SCLT1 | 1.39 |
| 326 | Basal cell nevus syndrome 1 | Enrichment | SUFU | 1.31 |
| 327 | Holoprosencephaly 1 | Enrichment | ZIC2 | 1.31 |
| 328 | Patent ductus arteriosus | Enrichment | INPP5E | 1.31 |
| 329 | Childhood absence epilepsy | Enrichment | EFHC1 | 1.31 |
| 330 | Short rib-polydactyly syndrome | Enrichment | NEK1 | 1.31 |
| 331 | Congenital muscular dystrophy with cerebellar involvement | Enrichment | POMGNT1 | 1.31 |
| 332 | Infertility | Enrichment | NPHP4 | 1.31 |
| 333 | Optic atrophy plus syndrome | Enrichment | NPHP3, RP1L1 | 1.29 |
| 334 | Cranioectodermal dysplasia 1 | Enrichment | CILK1 | 1.25 |
| 335 | Usher syndrome, type iiia | Enrichment | CEP78 | 1.25 |
| 336 | Leukoencephalopathy, brain calcifications, and cysts | Enrichment | TMEM107 | 1.25 |
| 337 | Brachydactyly | Enrichment | TULP1 | 1.25 |
| 338 | Muscular dystrophy-dystroglycanopathy | Enrichment | POMGNT1 | 1.25 |
| 339 | Cranioectodermal dysplasia | Enrichment | CILK1 | 1.25 |
| 340 | Motor neuron disease | Enrichment | NEK1 | 1.25 |
| 341 | Retinal degeneration | Enrichment | TULP1 | 1.25 |
| 342 | Hereditary clear cell renal cell carcinoma | Enrichment | FLCN | 1.25 |
| 343 | Congenital muscular dystrophy due to dystroglycanopathy | Enrichment | POMGNT1 | 1.25 |
| 344 | Moyamoya angiopathy | Enrichment | CEP78 | 1.25 |
| 345 | Spastic paraplegia 4, autosomal dominant | Enrichment | OFD1 | 1.19 |
| 346 | Isolated growth hormone deficiency, type ia | Enrichment | POC1A | 1.19 |
| 347 | Immunodeficiency 47 | Enrichment | CEP290 | 1.19 |
| 348 | Combined pituitary hormone deficiency | Enrichment | GLI2 | 1.19 |
| 349 | Cat eye syndrome | Enrichment | TMEM67 | 1.10 |
| 350 | Stickler syndrome | Enrichment | ALMS1 | 1.10 |
| 351 | Polymicrogyria | Enrichment | OFD1 | 1.10 |
| 352 | Muscle eye brain disease | Enrichment | POMGNT1 | 1.10 |
| 353 | Primary bone dysplasia | Enrichment | INPP5E | 1.10 |
| 354 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | CFAP410, NEK1 | 1.08 |
| 355 | Meningioma, familial | Enrichment | SUFU | 1.06 |
| 356 | Osteochondrodysplasia | Enrichment | INPP5E | 1.06 |
| 357 | Short-rib thoracic dysplasia 3 with or without polydactyly | Enrichment | NEK1 | 1.02 |
| 358 | Inherited cancer-predisposing syndrome | Enrichment | FLCN, PKD1, SUFU | 1.02 |
| 359 | Microphthalmia/coloboma 12 | Enrichment | TMEM67 | 0.99 |
| 360 | Diaphragmatic hernia, congenital | Enrichment | GLI3 | 0.99 |
| 361 | Osteoporosis | Enrichment | OFD1 | 0.96 |
| 362 | Walker-warburg syndrome | Enrichment | POMGNT1 | 0.96 |
| 363 | Seckel syndrome | Enrichment | PLK4 | 0.96 |
| 364 | Pituitary stalk interruption syndrome | Enrichment | GPR161 | 0.96 |
| 365 | Coloboma of macula | Enrichment | TMEM67 | 0.93 |
| 366 | Renal cell carcinoma, nonpapillary | Enrichment | FLCN | 0.93 |
| 367 | Hydrocephalus | Enrichment | POMGNT1 | 0.93 |
| 368 | Creatine phosphokinase, elevated serum | Enrichment | PKD1 | 0.91 |
| 369 | Isolated elevated serum creatine phosphokinase levels | Enrichment | PKD1 | 0.91 |
| 370 | Primary ciliary dyskinesia | Enrichment | DNAAF19, OFD1 | 0.89 |
| 371 | Cleft palate, isolated | Enrichment | INPP5E | 0.88 |
| 372 | Heart, malformation of | Enrichment | HYLS1 | 0.86 |
| 373 | Autosomal recessive limb-girdle muscular dystrophy | Enrichment | POMGNT1 | 0.84 |
| 374 | Leukodystrophy | Enrichment | ALMS1 | 0.82 |
| 375 | Focal segmental glomerulosclerosis | Enrichment | SDCCAG8 | 0.82 |
| 376 | Colorectal cancer | Enrichment | FLCN, PKHD1 | 0.79 |
| 377 | Non-syndromic male infertility due to sperm motility disorder | Enrichment | AK7 | 0.76 |
| 378 | Strabismus | Enrichment | KIF7 | 0.70 |
| 379 | Dystonia | Enrichment | CEP104 | 0.60 |
| 380 | Non-syndromic x-linked intellectual disability | Enrichment | USP9X | 0.59 |
| 381 | Microcephaly | Enrichment | CC2D2A, ZIC2 | 0.57 |
| 382 | Nonsyndromic hearing loss | Enrichment | DCDC2 | 0.53 |
| 383 | Sensorineural hearing loss | Enrichment | CEP78 | 0.48 |
| 384 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | GLI2 | 0.43 |
| 385 | Autosomal recessive non-syndromic intellectual disability | Enrichment | CEP104 | 0.42 |
| 386 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | DCDC2 | 0.28 |
| 387 | Ovarian cancer | Enrichment | FLCN | 0.25 |
| 388 | Autism spectrum disorder | Enrichment | CEP104 | 0.22 |